Table of Contents
1 Autoimmune Disorders Treatment Market Overview
1.1 Product Overview and Scope of Autoimmune Disorders Treatment
1.2 Classification of Autoimmune Disorders Treatment by Types
1.2.1 Global Autoimmune Disorders Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Autoimmune Disorders Treatment Revenue Market Share by Types in 2017
1.2.3 Bridge therapy
1.2.4 Recombinant technology
1.2.5 Fecal bacteriotherapy
1.2.6 Hematopoietic stem-cell transplantation
1.2.7 Phototherapy
1.2.8 Helminthic therapy
1.2.9 Activation-induced assays
1.2.10 Cytometry by time-of-flight mass spectrometry
1.3 Global Autoimmune Disorders Treatment Market by Application
1.3.1 Global Autoimmune Disorders Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Systemic autoimmune diseases
1.3.3 Localized autoimmune diseases
1.4 Global Autoimmune Disorders Treatment Market by Regions
1.4.1 Global Autoimmune Disorders Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Autoimmune Disorders Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Autoimmune Disorders Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autoimmune Disorders Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Autoimmune Disorders Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autoimmune Disorders Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Autoimmune Disorders Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Autoimmune Disorders Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche Diagnostics
2.2.1 Business Overview
2.2.2 Autoimmune Disorders Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Diagnostics Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Siemens Healthcare
2.3.1 Business Overview
2.3.2 Autoimmune Disorders Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Siemens Healthcare Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Autoimmune Disorders Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Autoimmune Disorders Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Autoimmune Disorders Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 AstraZeneca
2.7.1 Business Overview
2.7.2 Autoimmune Disorders Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AstraZeneca Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Autoimmune Disorders Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
2.9.1 Business Overview
2.9.2 Autoimmune Disorders Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Autoimmune Disorders Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Autoimmune Disorders Treatment Market Competition, by Players
3.1 Global Autoimmune Disorders Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Autoimmune Disorders Treatment Players Market Share
3.2.2 Top 10 Autoimmune Disorders Treatment Players Market Share
3.3 Market Competition Trend
4 Global Autoimmune Disorders Treatment Market Size by Regions
4.1 Global Autoimmune Disorders Treatment Revenue and Market Share by Regions
4.2 North America Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
5 North America Autoimmune Disorders Treatment Revenue by Countries
5.1 North America Autoimmune Disorders Treatment Revenue by Countries (2013-2018)
5.2 USA Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
6 Europe Autoimmune Disorders Treatment Revenue by Countries
6.1 Europe Autoimmune Disorders Treatment Revenue by Countries (2013-2018)
6.2 Germany Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
6.4 France Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Autoimmune Disorders Treatment Revenue by Countries
7.1 Asia-Pacific Autoimmune Disorders Treatment Revenue by Countries (2013-2018)
7.2 China Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
7.5 India Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
8 South America Autoimmune Disorders Treatment Revenue by Countries
8.1 South America Autoimmune Disorders Treatment Revenue by Countries (2013-2018)
8.2 Brazil Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Autoimmune Disorders Treatment by Countries
9.1 Middle East and Africa Autoimmune Disorders Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
10 Global Autoimmune Disorders Treatment Market Segment by Type
10.1 Global Autoimmune Disorders Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Autoimmune Disorders Treatment Market Forecast by Type (2018-2023)
10.3 Bridge therapy Revenue Growth Rate (2013-2023)
10.4 Recombinant technology Revenue Growth Rate (2013-2023)
10.5 Fecal bacteriotherapy Revenue Growth Rate (2013-2023)
10.6 Hematopoietic stem-cell transplantation Revenue Growth Rate (2013-2023)
10.7 Phototherapy Revenue Growth Rate (2013-2023)
10.8 Helminthic therapy Revenue Growth Rate (2013-2023)
10.9 Activation-induced assays Revenue Growth Rate (2013-2023)
10.10 Cytometry by time-of-flight mass spectrometry Revenue Growth Rate (2013-2023)
11 Global Autoimmune Disorders Treatment Market Segment by Application
11.1 Global Autoimmune Disorders Treatment Revenue Market Share by Application (2013-2018)
11.2 Autoimmune Disorders Treatment Market Forecast by Application (2018-2023)
11.3 Systemic autoimmune diseases Revenue Growth (2013-2018)
11.4 Localized autoimmune diseases Revenue Growth (2013-2018)
12 Global Autoimmune Disorders Treatment Market Size Forecast (2018-2023)
12.1 Global Autoimmune Disorders Treatment Market Size Forecast (2018-2023)
12.2 Global Autoimmune Disorders Treatment Market Forecast by Regions (2018-2023)
12.3 North America Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)
12.6 South America Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and FiguresFigure Autoimmune Disorders Treatment Picture
Table Product Specifications of Autoimmune Disorders Treatment
Table Global Autoimmune Disorders Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Autoimmune Disorders Treatment Revenue Market Share by Types in 2017
Figure Bridge therapy Picture
Figure Recombinant technology Picture
Figure Fecal bacteriotherapy Picture
Figure Hematopoietic stem-cell transplantation Picture
Figure Phototherapy Picture
Figure Helminthic therapy Picture
Figure Activation-induced assays Picture
Figure Cytometry by time-of-flight mass spectrometry Picture
Table Global Autoimmune Disorders Treatment Revenue (Million USD) by Application (2013-2023)
Figure Autoimmune Disorders Treatment Revenue Market Share by Applications in 2017
Figure Systemic autoimmune diseases Picture
Figure Localized autoimmune diseases Picture
Table Global Market Autoimmune Disorders Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Autoimmune Disorders Treatment Type and Applications
Table Abbott Laboratories Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table Roche Diagnostics Autoimmune Disorders Treatment Type and Applications
Table Roche Diagnostics Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Autoimmune Disorders Treatment Type and Applications
Table Siemens Healthcare Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Autoimmune Disorders Treatment Type and Applications
Table Johnson & Johnson Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Autoimmune Disorders Treatment Type and Applications
Table Boehringer Ingelheim Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Autoimmune Disorders Treatment Type and Applications
Table GlaxoSmithKline Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Autoimmune Disorders Treatment Type and Applications
Table AstraZeneca Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Autoimmune Disorders Treatment Type and Applications
Table Sanofi Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Autoimmune Disorders Treatment Type and Applications
Table Merck Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Autoimmune Disorders Treatment Type and Applications
Table Pfizer Autoimmune Disorders Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Autoimmune Disorders Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Autoimmune Disorders Treatment Revenue Share by Players (2013-2018)
Figure Global Autoimmune Disorders Treatment Revenue Share by Players in 2016
Figure Global Autoimmune Disorders Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Autoimmune Disorders Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Autoimmune Disorders Treatment Revenue Market Share in 2017
Figure Global Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Autoimmune Disorders Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Autoimmune Disorders Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Autoimmune Disorders Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Autoimmune Disorders Treatment Revenue Market Share by Regions in 2017
Figure North America Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure South America Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Table North America Autoimmune Disorders Treatment Revenue by Countries (2013-2018)
Table North America Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Autoimmune Disorders Treatment Revenue Market Share by Countries in 2017
Figure USA Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Table Europe Autoimmune Disorders Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Autoimmune Disorders Treatment Revenue Market Share by Countries in 2017
Figure Germany Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure UK Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure France Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Autoimmune Disorders Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Autoimmune Disorders Treatment Revenue Market Share by Countries in 2017
Figure China Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure India Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Table South America Autoimmune Disorders Treatment Revenue by Countries (2013-2018)
Table South America Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Autoimmune Disorders Treatment Revenue Market Share by Countries in 2017
Figure Brazil Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Autoimmune Disorders Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Autoimmune Disorders Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Autoimmune Disorders Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Autoimmune Disorders Treatment Revenue and Growth Rate (2013-2018)
Table Global Autoimmune Disorders Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Autoimmune Disorders Treatment Revenue Share by Type (2013-2018)
Figure Global Autoimmune Disorders Treatment Revenue Share by Type (2013-2018)
Figure Global Autoimmune Disorders Treatment Revenue Share by Type in 2017
Table Global Autoimmune Disorders Treatment Revenue Forecast by Type (2018-2023)
Figure Global Autoimmune Disorders Treatment Market Share Forecast by Type (2018-2023)
Figure Global Bridge therapy Revenue Growth Rate (2013-2018)
Figure Global Recombinant technology Revenue Growth Rate (2013-2018)
Figure Global Fecal bacteriotherapy Revenue Growth Rate (2013-2018)
Figure Global Hematopoietic stem-cell transplantation Revenue Growth Rate (2013-2018)
Figure Global Phototherapy Revenue Growth Rate (2013-2018)
Figure Global Helminthic therapy Revenue Growth Rate (2013-2018)
Figure Global Activation-induced assays Revenue Growth Rate (2013-2018)
Figure Global Cytometry by time-of-flight mass spectrometry Revenue Growth Rate (2013-2018)
Table Global Autoimmune Disorders Treatment Revenue by Application (2013-2018)
Table Global Autoimmune Disorders Treatment Revenue Share by Application (2013-2018)
Figure Global Autoimmune Disorders Treatment Revenue Share by Application (2013-2018)
Figure Global Autoimmune Disorders Treatment Revenue Share by Application in 2017
Table Global Autoimmune Disorders Treatment Revenue Forecast by Application (2018-2023)
Figure Global Autoimmune Disorders Treatment Market Share Forecast by Application (2018-2023)
Figure Global Systemic autoimmune diseases Revenue Growth Rate (2013-2018)
Figure Global Localized autoimmune diseases Revenue Growth Rate (2013-2018)
Figure Global Autoimmune Disorders Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Autoimmune Disorders Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Autoimmune Disorders Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)
Figure Europe Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)
Figure South America Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Autoimmune Disorders Treatment Revenue Market Forecast (2018-2023)
【レポートのキーワード】
自己免疫疾患治療、ブリッジ治療、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、その他、全身性自己免疫疾患、限局性自己免疫疾患